241
Participants
Start Date
December 9, 2014
Primary Completion Date
August 14, 2017
Study Completion Date
August 14, 2017
GS-4774
Exposure of interest for participants who received GS-4774 (administered as a subcutaneous injection) in a previous Gilead study for chronic hepatitis B virus infection.
GS-9620
Exposure of interest for participants who received GS-9620 (tablets administered orally) in a previous Gilead study for chronic hepatitis B virus infection.
Tenofovir disoproxil fumarate (TDF)
Exposure of interest for participants who received TDF (tablets administered orally) in a previous Gilead study for chronic hepatitis B virus infection.
Kaiser Permanente, Sacramento
Kaiser Permanente, San Diego
Kaiser Permanente, San Francisco
Silicon Valley Research Institute, San Jose
University of Miami, Miami
The Queen's Medical Center, Honolulu
Northwestern University, Chicago
Digestive Disease Associates, PA, Baltimore
Tufts Medical Center, Boston
University of Michigan, Ann Arbor
Henry Ford Hospital, Detroit
St. Louis University, St Louis
Medical Procare, PLL, Flushing
Northwell Health, Manhasset
Xiaoli Ma, PC, Philadelphia
Bon Secours St. Mary's Hospital of Richmond, Newport News
Royal Prince Alfred Hospital, Camperdown
University of Calgary, Calgary
Gordon and Leslie Diamond Health Care Centre, Vancouver
Liver and Intestinal Research Centre, Vancouver
University of Manitoba, Winnepeg
Toronto General Hospital, Toronto
Princess Margaret Hospital, Lai Chi Kok
Prince of Wales Hospital, Shatin
Nirmal Hospital Private Limited, Surat
Midas Multispecialty Hospital Private Limited, Nagpur
Dept. of Hepatology, School of Digestive & Liver Diseases, Kolkata
IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo
Azienda Ospedaliera Universitaria Pisana, Caianello
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
Azienda Ospedaliera Universitaria di Parma, Parma
Auckland City Hospital, Auckland
Pusan National, Busan
Korea University, Seoul
Samsung Medical Center, Seoul
Seoul National University Bundang Hospital, Seoul
Yonsei University, Seoul
Lead Sponsor
Gilead Sciences
INDUSTRY